Literature DB >> 14593183

Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.

Wen G Chen1, Qiang Chang, Yingxi Lin, Alexander Meissner, Anne E West, Eric C Griffith, Rudolf Jaenisch, Michael E Greenberg.   

Abstract

Mutations in MeCP2, which encodes a protein that has been proposed to function as a global transcriptional repressor, are the cause of Rett syndrome (RT T), an X-linked progressive neurological disorder. Although the selective inactivation of MeCP2 in neurons is sufficient to confer a Rett-like phenotype in mice, the specific functions of MeCP2 in postmitotic neurons are not known. We find that MeCP2 binds selectively to BDNF promoter III and functions to repress expression of the BDNF gene. Membrane depolarization triggers the calcium-dependent phosphorylation and release of MeCP2 from BDNF promoter III, thereby facilitating transcription. These studies indicate that MeCP2 plays a key role in the control of neuronal activity-dependent gene regulation and suggest that the deregulation of this process may underlie the pathology of RT T.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593183     DOI: 10.1126/science.1086446

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  503 in total

1.  Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome.

Authors:  Hao Wu; Jifang Tao; Pauline J Chen; Atif Shahab; Weihong Ge; Ronald P Hart; Xiaoan Ruan; Yijun Ruan; Yi E Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Elevation of BDNF exon I-specific transcripts in the frontal cortex and midbrain of rat during spontaneous morphine withdrawal is accompanied by enhanced pCreb1 occupancy at the corresponding promoter.

Authors:  Danil I Peregud; Leonid F Panchenko; Natalia V Gulyaeva
Journal:  Neurochem Res       Date:  2014-11-13       Impact factor: 3.996

Review 3.  Complexities of Rett syndrome and MeCP2.

Authors:  Rodney C Samaco; Jeffrey L Neul
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 4.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

5.  Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia.

Authors:  J C Russell; M E Blue; M V Johnston; S Naidu; M A Hossain
Journal:  Neuroscience       Date:  2007-10-11       Impact factor: 3.590

6.  Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology.

Authors:  Nurit Ballas; Daniel T Lioy; Christopher Grunseich; Gail Mandel
Journal:  Nat Neurosci       Date:  2009-02-22       Impact factor: 24.884

7.  Conditional Dnmt1 deletion in dorsal forebrain disrupts development of somatosensory barrel cortex and thalamocortical long-term potentiation.

Authors:  Peyman Golshani; Leah Hutnick; Felix Schweizer; Guoping Fan
Journal:  Thalamus Relat Syst       Date:  2005-09

8.  Regulation of brain-derived neurotrophic factor expression in neurons.

Authors:  Fei Zheng; Xianju Zhou; Changjong Moon; Hongbing Wang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

9.  Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance.

Authors:  Xuan Li; M R DeJoseph; Janice H Urban; Amine Bahi; Jean-Luc Dreyer; Gloria E Meredith; Kerstin A Ford; Carrie R Ferrario; Jessica A Loweth; Marina E Wolf
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

Review 10.  Activity-dependent neuronal signalling and autism spectrum disorder.

Authors:  Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.